Your browser doesn't support javascript.
loading
Antibody-mediated blockade for galectin-3 binding protein in tumor secretome abrogates PDAC metastasis.
Choi, Yeon-Sook; Kim, Myung Ji; Choi, Eun A; Kim, Sinae; Lee, Eun Ji; Park, Min Ji; Kim, Mi-Ju; Kim, Yeon Wook; Ahn, Hee-Sung; Jung, Jae Yun; Jang, Gayoung; Kim, Yongsub; Kim, Hyori; Kim, Kyunggon; Kim, Jin Young; Hong, Seung-Mo; Kim, Song Cheol; Chang, Suhwan.
Afiliación
  • Choi YS; Department of Biomedical Sciences, University of Ulsan College of Medicine, Asan Medical Center, Seoul 05505, South Korea.
  • Kim MJ; Department of Biomedical Sciences, University of Ulsan College of Medicine, Asan Medical Center, Seoul 05505, South Korea.
  • Choi EA; Department of Biomedical Sciences, University of Ulsan College of Medicine, Asan Medical Center, Seoul 05505, South Korea.
  • Kim S; Department of Biomedical Sciences, University of Ulsan College of Medicine, Asan Medical Center, Seoul 05505, South Korea.
  • Lee EJ; Department of Biomedical Sciences, University of Ulsan College of Medicine, Asan Medical Center, Seoul 05505, South Korea.
  • Park MJ; Department of Biomedical Sciences, University of Ulsan College of Medicine, Asan Medical Center, Seoul 05505, South Korea.
  • Kim MJ; Asan Institute for Life Sciences, Asan Medical Center, Seoul, 05505, South Korea.
  • Kim YW; Asan Institute for Life Sciences, Asan Medical Center, Seoul, 05505, South Korea.
  • Ahn HS; Department of Convergence Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul 05505, South Korea.
  • Jung JY; Department of Biomedical Sciences, University of Ulsan College of Medicine, Asan Medical Center, Seoul 05505, South Korea.
  • Jang G; Department of Biomedical Sciences, University of Ulsan College of Medicine, Asan Medical Center, Seoul 05505, South Korea.
  • Kim Y; Department of Biomedical Sciences, University of Ulsan College of Medicine, Asan Medical Center, Seoul 05505, South Korea.
  • Kim H; Department of Convergence Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul 05505, South Korea.
  • Kim K; Department of Convergence Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul 05505, South Korea.
  • Kim JY; Research Center for Bioconvergence Analysis, Korea Basic Science Institute, Ochang, 28119, South Korea.
  • Hong SM; Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul 05505, South Korea.
  • Kim SC; Division of Hepato-Biliary and Pancreatic Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul 05505, South Korea.
  • Chang S; Department of Biomedical Sciences, University of Ulsan College of Medicine, Asan Medical Center, Seoul 05505, South Korea.
Proc Natl Acad Sci U S A ; 119(30): e2119048119, 2022 07 26.
Article en En | MEDLINE | ID: mdl-35858411
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Biomarcadores de Tumor / Carcinoma Ductal Pancreático / Antineoplásicos Inmunológicos / Antígenos de Neoplasias Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2022 Tipo del documento: Article País de afiliación: Corea del Sur Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Biomarcadores de Tumor / Carcinoma Ductal Pancreático / Antineoplásicos Inmunológicos / Antígenos de Neoplasias Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2022 Tipo del documento: Article País de afiliación: Corea del Sur Pais de publicación: Estados Unidos